Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CNY | -100.0% |
| 2022 | 3.15 Million CNY | -75.05% |
| 2021 | 12.64 Million CNY | -37.72% |
| 2020 | 20.3 Million CNY | -24.91% |
| 2019 | 27.04 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - CNY | 0.0% |
| 2024 Q2 | - CNY | 0.0% |
| 2023 Q2 | - CNY | 0.0% |
| 2023 FY | - CNY | -100.0% |
| 2023 Q4 | - CNY | 0.0% |
| 2023 Q1 | - CNY | -100.0% |
| 2023 Q3 | - CNY | 0.0% |
| 2022 Q1 | 8.2 Million CNY | -35.13% |
| 2022 FY | 3.15 Million CNY | -75.05% |
| 2022 Q4 | 3.15 Million CNY | 0.0% |
| 2022 Q3 | 3.15 Million CNY | -61.53% |
| 2022 Q2 | 8.2 Million CNY | 0.0% |
| 2021 Q1 | 6.14 Billion CNY | 30153.82% |
| 2021 FY | 12.64 Million CNY | -37.72% |
| 2021 Q2 | 18.16 Million CNY | -99.7% |
| 2021 Q3 | 12.64 Million CNY | -30.38% |
| 2021 Q4 | 12.64 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 20.3 Million CNY | -24.91% |
| 2020 Q4 | 20.3 Million CNY | -99.16% |
| 2020 Q3 | 2.42 Billion CNY | 0.0% |
| 2019 FY | 27.04 Million CNY | 0.0% |